Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329
शेयरों में रैंक
#4374
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its... Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, along with its subsidiaries, primarily manufactures and markets traditional Chinese medicine, Western pharmaceuticals, and various healthcare products within the People's Republic of China. Its business activities are structured into two distinct divisions: Chinese Medicine and Western Medicine. The company's operations extend beyond its core offerings to include the production and distribution of Chinese, Western, and biological pharmaceutical items. It also engages in the wholesale and retail trade of medicines, biochemical pharmaceutical products, and everyday consumer goods, in addition to managing hospitals. Furthermore, Tianjin Pharmaceutical Da Ren Tang provides a comprehensive suite of services such as logistics, inventory management, equipment installation, and drug processing. It also offers pharmaceutical inspection, testing, and advisory services. In terms of its commercial model, the company supplies its proprietary branded medicinal products directly to wholesalers. Conversely, it acquires pharmaceuticals marketed under other brands from distributors, subsequently reselling these to other wholesale clients. Established in 1992 and based in Tianjin, People's Republic of China, the company was previously known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited before adopting its current name in May 2022.
शेयर मूल्य
$6.17
मार्केट कैप
$3.52B
बदलाव (1 दिन)
-0.05%
बदलाव (1 वर्ष)
-1.86%
देश
CN
व्यापार Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329)
श्रेणी
Healthcare
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) के लिए बकाया शेयरों की संख्या
October 2026 की स्थिति में बकाया शेयरों की संख्या: 0
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 0 है। October 2026 के अंत में कंपनी के पास 0 बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329) के लिए 2001 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
| वर्ष | बकाया शेयर | परिवर्तन |
|---|---|---|
| 2025 | 769.32M | -0.11% |
| 2024 | 770.16M | -0.09% |
| 2023 | 770.87M | 0.26% |
| 2022 | 768.87M | 0.00% |
| 2021 | 768.87M | 0.00% |
| 2020 | 768.87M | 0.00% |
| 2019 | 768.87M | 0.00% |
| 2018 | 768.87M | 0.13% |
| 2017 | 767.87M | -0.13% |
| 2016 | 768.87M | 2.19% |
| 2015 | 752.40M | 0.94% |
| 2014 | 745.42M | 1.71% |
| 2013 | 732.90M | -0.35% |
| 2012 | 735.50M | -1.99% |
| 2011 | 750.45M | 2.35% |
| 2010 | 733.22M | -0.46% |
| 2009 | 736.62M | 0.37% |
| 2008 | 733.90M | -0.34% |
| 2007 | 736.38M | 0.01% |
| 2006 | 736.29M | 0.00% |
| 2005 | 736.29M | 0.00% |
| 2004 | 736.29M | 0.00% |
| 2003 | 736.29M | 0.00% |
| 2002 | 736.29M | 0.00% |
| 2001 | 736.29M | 0.00% |
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
| कंपनी | बकाया शेयर | अंतर | देश |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
